Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New blood test to help vets spot liver disease in dogs
Out of 250 dogs tested, those with liver disease were found to have significantly higher levels of miR-122.
Test created using insights from human medicine 

Vets and doctors have teamed up to develop a blood test that could spot the early signs of liver disease in dogs.

The test is set to be launched worldwide and could help vets to identify damage and start treatment early.

As well as saving many lives, it will reduce the number of dogs that have to undergo invasive liver biopsies, according to the University of Edinburgh.

Diagnosis of liver disease in dogs is challenging and spotting the early signs of damage is key to treatment. Current diagnosis is based on biopsies, which are expensive and can lead to complications.

Vets at the University’s Royal (Dick) School of Veterinary Studies worked with medical doctors to look at blood levels of the molecule miR-122 in dogs. In humans with liver disease, the molecule is found in high levels.

Out of 250 dogs tested, those with liver disease were found to have significantly higher levels of miR-122, compared with healthy dogs and those with different diseases that did not affect the liver.

Lead veterinary researcher, Professor Richard Mellanby, said: “We have found a specific, sensitive and non-invasive way to detect liver damage in dogs. We hope that our test will greatly improve outcomes by allowing vets to make rapid and accurate diagnosis.”
 
NHS doctor Dr James Dear, who co-led the study, added: “I am delighted that the blood test we developed to improve the diagnosis of liver disease in humans can be used to help dogs too.”

The team plan to launch a testing kit worldwide.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.